Clinical Trial Update: BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) [Phase 4]

View source ↗

Summary

Phase 4 BOAT trial assessing beta blocker uptitration with OptiVol after Cardiac Resynchronization Therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Beta-blockers (unspecified)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Congestive Heart Failure | Phase 4 | Status: TERMINATED